Evidence map›Paper›PMID 41042145›Full record

ArticleRadiology. Imaging cancer2025

Safety and Efficacy of Thermal Ablation for Benign Thyroid Nodules in Patients with or without Previous Thyroid Surgery.

Meng-Yu Lu, Wen-Wen Yue, Jia-Xin Li, Jing-E Zhu, Xiao-Wan Bo, Hui-Li Zhang, Yin-Cheng Gao, Guan-Qun Zhang, Hao-Jie Yang, Li-Ping Sun

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Radiology. Imaging cancer, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Meng-Yu Lu *Department of Medical Ultrasound, Center of Minimally Invasive Treatment for Tumor, Shanghai Tenth People's Hospital, Ultrasound Research and Education Institute, Clinical Research Center for Interventional Medicine, School of Medicine, Tongji University, 301 Yanchangzhong Rd, Shanghai 200072, China.
Wen-Wen Yue *Department of Medical Ultrasound, Center of Minimally Invasive Treatment for Tumor, Shanghai Tenth People's Hospital, Ultrasound Research and Education Institute, Clinical Research Center for Interventional Medicine, School of Medicine, Tongji University, 301 Yanchangzhong Rd, Shanghai 200072, China.ORCID 0000-0002-7121-591X
Jia-Xin LiDepartment of Medical Ultrasound, Center of Minimally Invasive Treatment for Tumor, Shanghai Tenth People's Hospital, Ultrasound Research and Education Institute, Clinical Research Center for Interventional Medicine, School of Medicine, Tongji University, 301 Yanchangzhong Rd, Shanghai 200072, China.
Jing-E ZhuDepartment of Medical Ultrasound, Center of Minimally Invasive Treatment for Tumor, Shanghai Tenth People's Hospital, Ultrasound Research and Education Institute, Clinical Research Center for Interventional Medicine, School of Medicine, Tongji University, 301 Yanchangzhong Rd, Shanghai 200072, China.ORCID 0000-0003-2841-0733
Xiao-Wan BoDepartment of Medical Ultrasound, Center of Minimally Invasive Treatment for Tumor, Shanghai Tenth People's Hospital, Ultrasound Research and Education Institute, Clinical Research Center for Interventional Medicine, School of Medicine, Tongji University, 301 Yanchangzhong Rd, Shanghai 200072, China.
Hui-Li ZhangDepartment of Medical Ultrasound, Center of Minimally Invasive Treatment for Tumor, Shanghai Tenth People's Hospital, Ultrasound Research and Education Institute, Clinical Research Center for Interventional Medicine, School of Medicine, Tongji University, 301 Yanchangzhong Rd, Shanghai 200072, China.
Yin-Cheng GaoDepartment of Medical Ultrasound, Center of Minimally Invasive Treatment for Tumor, Shanghai Tenth People's Hospital, Ultrasound Research and Education Institute, Clinical Research Center for Interventional Medicine, School of Medicine, Tongji University, 301 Yanchangzhong Rd, Shanghai 200072, China.
Guan-Qun ZhangDepartment of Medical Ultrasound, Center of Minimally Invasive Treatment for Tumor, Shanghai Tenth People's Hospital, Ultrasound Research and Education Institute, Clinical Research Center for Interventional Medicine, School of Medicine, Tongji University, 301 Yanchangzhong Rd, Shanghai 200072, China.
Hao-Jie YangDepartment of Medical Ultrasound, Center of Minimally Invasive Treatment for Tumor, Shanghai Tenth People's Hospital, Ultrasound Research and Education Institute, Clinical Research Center for Interventional Medicine, School of Medicine, Tongji University, 301 Yanchangzhong Rd, Shanghai 200072, China.
Li-Ping SunDepartment of Medical Ultrasound, Center of Minimally Invasive Treatment for Tumor, Shanghai Tenth People's Hospital, Ultrasound Research and Education Institute, Clinical Research Center for Interventional Medicine, School of Medicine, Tongji University, 301 Yanchangzhong Rd, Shanghai 200072, China.ORCID 0000-0002-4301-4520

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Purpose To examine the use of propensity score matching (PSM) to compare the safety and efficacy of US-guided thermal ablation (TA) as a first-line treatment for initial thyroid nodules versus as a second-line treatment for recurrent nodules following thyroid surgery. Materials and Methods This retrospective study included data from 693 patients with benign thyroid nodules (BTNs) who underwent US-guided TA between January 2015 and July 2023. These included 619 patients in the initial nodule group and 74 patients in the recurrent nodule group. PSM was employed to balance preablation data and minimize confounding bias between the two groups. The perioperative and post-TA complication rates of the two matched patient groups were compared. Nodule volume and volume reduction rate (VRR) were compared at 1, 3, 6, and 12 months after TA. Thyroid function, symptoms, and cosmetic scores were also compared. Results Successful matching of 222 patients (mean age ± SD, 55.92 years ± 12.08; 172 female) (2:1 ratio) was achieved, with 148 patients in the initial nodule group and 74 patients in the recurrent nodule group. There was no evidence of a difference between the two groups regarding incidence of major complications (

Indexed as

Ablation TechniquesRadiofrequency AblationThyroid NoduleUltrasonography, InterventionalAdultAgedFemaleHumansMaleMiddle AgedPropensity ScoreRetrospective StudiesThyroidectomyThyroid GlandTreatment OutcomeAblation Techniques (Radiofrequency, Thermal, Chemical)Efficacy StudiesHead/NeckThyroidTreatment Effects

Identifiers

PMID41042145
PMCPMC12670015

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.